Information about Pharmavox
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0841.606.444

VAT liability
Yes
Established
02-12-2011
Last balance sheet year
2025
Company size
Medium-sized 0 FTE
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pharmavox

2025 2024 2023 2022
Profit/Loss € -323,574 -47 % € -220,359 34 % € -331,487 -41 % € -235,527
Equity € 6,880,711 -4 % € 7,204,285 -3 % € 7,424,645 -4 % € 7,756,132
Gross margin € 353,155 -18 % € 429,765 25 % € 343,727 2 % € 336,332

Publications from Pharmavox

Date Publication
28-03-2024 Registered Office Relocation (FR)
12-03-2020 Capital, Shares (FR)
08-08-2019 Capital, Shares (FR)
17-05-2019 Resignations, Appointments - Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form (FR)
16-10-2015 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of Pharmavox?
The VAT number of Pharmavox is BE 0841.606.444.
Wat is the PEPPOL ID of Pharmavox?
The PEPPOL ID of Pharmavox is 0208:0841606444. Log in or start a free trial to see the full overview.
When was Pharmavox founded?
Pharmavox was founded on 02-12-2011.
What is the address of Pharmavox?
The current registered office of Pharmavox is located at Chaussée de La Hulpe 178/5, 1170 Watermael-Boitsfort.
When was the last time Pharmavox filed their annual financial statements?
The most recent financial statements of Pharmavox were filed on 28-10-2025.
How many employees does Pharmavox have?
There are currently no employees working at Pharmavox or no workforce information is available.
What is the annual turnover of Pharmavox?
At the time of its most recent financial statements, Pharmavox did not publish any turnover figures. Pharmavox reported a gross margin of €353,154.81.

Sources